Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosing polycythemia vera: a paradigm shift.

A Tefferi1

  • 1Division of Hematology and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.

Mayo Clinic Proceedings
|March 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of <i>DYRK1A</i>.

bioRxiv : the preprint server for biology·2023
Same author

Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2023
Same author

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3".

Blood cancer journal·2022
Same author

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.

Blood cancer journal·2022
Same author

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients.

Blood cancer journal·2018
Same author

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

Blood cancer journal·2017

Diagnosing polycythemia vera (PV) requires distinguishing it from other conditions. This study explores using serum erythropoietin levels and endogenous erythroid colony assays as potential diagnostic alternatives.

Area of Science:

  • Hematology
  • Oncology
  • Diagnostic Medicine

Background:

  • Accurate diagnosis of polycythemia vera (PV) is crucial due to differing prognoses and treatments.
  • Distinguishing PV from relative polycythemia and secondary erythrocytosis is essential.
  • Current diagnostic methods rely on red blood cell mass, plasma volume, and oxygen saturation measurements.

Purpose of the Study:

  • To evaluate the utility of serum erythropoietin (EPO) levels in diagnosing PV.
  • To assess the role of endogenous erythroid colony (EEC) assays as an alternative diagnostic tool for PV.
  • To explore novel diagnostic approaches for PV beyond traditional methods.

Main Methods:

  • Review of current diagnostic criteria for PV.
  • Discussion of serum EPO level measurement techniques.

Related Experiment Videos

  • Explanation of the endogenous erythroid colony assay procedure.
  • Comparison of proposed methods with established diagnostic standards.

    • Main Results:

    • Serum EPO levels are typically low in PV patients.
    • EEC assays can detect abnormal erythroid progenitor growth characteristic of PV.
    • These markers offer potential for differentiating PV from other causes of erythrocytosis.

    Conclusions:

    • Serum EPO levels and EEC assays show promise as adjunctive or alternative diagnostic tools for PV.
    • These methods may simplify PV diagnosis by potentially reducing the need for invasive red blood cell mass measurements.
    • Further validation is needed to establish these assays within standard clinical practice for PV diagnosis.